Prognostic value of the glucose-to-lymphocyte ratio in surgically treated endometrial cancer: a retrospective cohort study
GLR is an independent prognostic factor for DFS in endometrial cancer and may serve as a readily available, cost-effective biomarker. Further prospective studies are needed for validation.
Authors
- Furkan Ceylan (ORCID: https://orcid.org/0000-0002-1944-0861)
- Safa Can Efil (ORCID: https://orcid.org/0000-0001-9586-2858)
- Burak Civelek (ORCID: https://orcid.org/0000-0002-5627-599X)
- Didem Şener Dede (ORCID: https://orcid.org/0000-0002-9756-5942)
- Serhat Sekmek (ORCID: https://orcid.org/0000-0003-4650-248X)
- Ateş Kutay Tenekeci (ORCID: https://orcid.org/0009-0007-6224-945X)
- Bülent Yalçın (ORCID: https://orcid.org/0000-0002-4431-8948)
- Efnan Algın
- Sena Kaya Ceylan
- M.Bülent Akıncı
- Fahriye Tuba Köş
- Mehmet Ali Nahit Şendur
Institutions
- SAIT Polytechnic (CA)
- Bilkent University (TR)
- Ankara Bilkent City Hospital (TR)
- Hacettepe University (TR)
Publication Details
- Journal
- Future Oncology
- Published
- 2026-01-28
- DOI
- https://doi.org/10.1080/14796694.2026.2622299
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00